108 related articles for article (PubMed ID: 2801549)
41. Circadian variation of total ischaemic burden and its alteration with anti-anginal agents.
Mulcahy D; Keegan J; Cunningham D; Quyyumi A; Crean P; Park A; Wright C; Fox K
Lancet; 1988 Oct; 2(8614):755-9. PubMed ID: 2901609
[TBL] [Abstract][Full Text] [Related]
42. Spectral analysis of heart rate variability before and during episodes of nocturnal ischaemia in patients with extensive coronary artery disease.
Vardas PE; Kochiadakis GE; Manios EG; Kanoupakis EM; Zouridakis EG; Chlouverakis GI
Eur Heart J; 1996 Mar; 17(3):388-93. PubMed ID: 8737212
[TBL] [Abstract][Full Text] [Related]
43. Efficacy of metoprolol and diltiazem in treating silent myocardial ischemia.
Portegies MC; Sijbring P; Göbel EJ; Viersma JW; Lie KI
Am J Cardiol; 1994 Dec; 74(11):1095-8. PubMed ID: 7977065
[TBL] [Abstract][Full Text] [Related]
44. Effect of nifedipine on total ischemic activity and circadian distribution of myocardial ischemic episodes in angina pectoris.
Nesto RW; Phillips RT; Kett KG; McAuliffe LS; Roberts M; Hegarty P
Am J Cardiol; 1991 Jan; 67(2):128-32. PubMed ID: 1987713
[TBL] [Abstract][Full Text] [Related]
45. Treatment of hypertension associated with stable angina pectoris: favourable interaction between new metoprolol formulation (OROS) and nifedipine.
Di Somma S; de Divitiis M; Bertocchi F; Carotenuto A; Cudemo G; Petitto M; Napodano M; de Divitiis O
Cardiologia; 1996 Jul; 41(7):635-43. PubMed ID: 8831181
[TBL] [Abstract][Full Text] [Related]
46. Hemodynamic and electrocardiographic correlates of symptomatic and silent myocardial ischemia: pathophysiologic and therapeutic implications.
Singh BN; Nademanee K; Figueras J; Josephson MA
Am J Cardiol; 1986 Aug; 58(4):3B-10B. PubMed ID: 3751901
[TBL] [Abstract][Full Text] [Related]
47. Heart rate, magnitude and duration of ST-segment depression in symptomatic and asymptomatic episodes of myocardial ischemia in patients with coronary artery disease recorded by Holter.
Ilić S
Acta Med Iugosl; 1989; 43(3):205-13. PubMed ID: 2741722
[TBL] [Abstract][Full Text] [Related]
48. Beta-adrenergic blockers in silent myocardial ischemia.
Pepine CJ; Hill JA; Imperi GA; Norvell N
Am J Cardiol; 1988 Jan; 61(3):18B-21B. PubMed ID: 2893528
[TBL] [Abstract][Full Text] [Related]
49. [Blood pressure variability and transient myocardial ischemia in patients with essential hypertension].
Lanitz EC; Gonska BD; Schrader J
Z Kardiol; 1992; 81 Suppl 2():37-9. PubMed ID: 1514310
[TBL] [Abstract][Full Text] [Related]
50. Origins of heart rate variability: autonomic blockade of large magnitude, transient bradycardia in conscious rabbits.
Roach D; Thakore E; Sheldon R
Can J Cardiol; 2001 Feb; 17(2):185-91. PubMed ID: 11223489
[TBL] [Abstract][Full Text] [Related]
51. Circadian and power spectral changes of RR and QT intervals during treatment of patients with angina pectoris with nadolol providing evidence for differential autonomic modulation of heart rate and ventricular repolarization.
Sarma JS; Singh N; Schoenbaum MP; Venkataraman K; Singh BN
Am J Cardiol; 1994 Jul; 74(2):131-6. PubMed ID: 8023776
[TBL] [Abstract][Full Text] [Related]
52. [Silent myocardial ischemia in patients after myocardial infarction].
Moczurad KW; Grodecki JK; Dubiel JP; Curyło AM
Kardiol Pol; 1989; 32 Suppl 2():17-24. PubMed ID: 2634149
[TBL] [Abstract][Full Text] [Related]
53. Carvedilol versus metoprolol in the acute phase of myocardial infarction:
Bonnemeier H; Ortak J; Tölg R; Witt M; Schmidt J; Wiegand UK; Bode F; Schunkert H; Richardt G
Pacing Clin Electrophysiol; 2005 Jan; 28 Suppl 1():S222-6. PubMed ID: 15683501
[TBL] [Abstract][Full Text] [Related]
54. Characteristics of silent myocardial ischemia during out-of-hospital activities in asymptomatic angiographically documented coronary artery disease.
Cohn PF; Lawson WE
Am J Cardiol; 1987 Apr; 59(8):746-9. PubMed ID: 3825933
[TBL] [Abstract][Full Text] [Related]
55. Acute effects of combined alpha/beta-adrenoceptor blockade v combined beta-receptor and slow channel calcium blockade in ischemic heart disease complicated by hypertension. Hemodynamic and adrenergic responses.
Koch G; Fransson L
Am J Hypertens; 1991 Aug; 4(8):709-13. PubMed ID: 1681821
[TBL] [Abstract][Full Text] [Related]
56. Comparison of selective (beta 1) and nonselective (beta 1 and beta 2) beta-adrenergic blockade on systemic and coronary hemodynamic findings in angina pectoris.
Prida XE; Feldman RL; Hill JA; Pepine CJ
Am J Cardiol; 1987 Aug; 60(4):244-8. PubMed ID: 2887101
[TBL] [Abstract][Full Text] [Related]
57. Circadian variation of ambulatory myocardial ischemia. Triggering by daily activities and evidence for an endogenous circadian component.
Krantz DS; Kop WJ; Gabbay FH; Rozanski A; Barnard M; Klein J; Pardo Y; Gottdiener JS
Circulation; 1996 Apr; 93(7):1364-71. PubMed ID: 8641025
[TBL] [Abstract][Full Text] [Related]
58. Waking and rising at night as a trigger of myocardial ischemia.
Barry J; Campbell S; Yeung AC; Raby KE; Selwyn AP
Am J Cardiol; 1991 May; 67(13):1067-72. PubMed ID: 2024595
[TBL] [Abstract][Full Text] [Related]
59. Current concepts of pathophysiology, circadian patterns, and vasoreactive factors associated with myocardial ischemia detected by ambulatory electrocardiography.
Quyyumi AA
Cardiol Clin; 1992 Aug; 10(3):403-15. PubMed ID: 1504972
[TBL] [Abstract][Full Text] [Related]
60. Effect of diltiazem slow-release formulation on silent myocardial ischemia in stable coronary artery disease. The Canadian Multicenter Diltiazem Study Group.
Juneau M; Théroux P; Waters D
Am J Cardiol; 1992 Mar; 69(7):30B-35B. PubMed ID: 1543140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
